Two common medications that are categorized as blood thinners and used to prevent blood clots are anticoagulants and antiplatelets. Both are essential in treating conditions caused by blood clots ...

Investigators believe that this new anticoagulant, named tecarfarin, will be associated with less therapeutic variability than warfarin because its structure precludes it from being metabolized by ...

The ageing population and the increasing prevalence of conditions like atrial fibrillation are driving significant growth in the anticoagulant reversal drugs market in the Asia Pacific ...

Researchers used feedback from patient focus groups to develop tools and recommendations for shared anticoagulant ...

Many more suffer morbidity due to complications. These events occur despite the availability of anticoagulants, which, while effective, bring risk of severe or fatal bleeding. These risks lead ...

TAHO Pharmaceuticals announces positive preliminary results from the pivotal study of TAH3311, the world's first Apixaban oral dissolving film (ODF). The study confirmed that TAH3311 is bioequivalent ...